Logo
Understanding Why Treatments Work – or Don’t – One Cell at a Time

A disease is more than a collection of cells

This is where SPADE (Spatial Profiling and Disease Exploration) comes in. Launched by SingHealth Duke-NUS AMC, SPADE brings together clinicians, pathologists, biomedical scientists, and data scientists to better understand why the same treatment produces such different results in different patients.

Unpacking more, with a single tissue sample

Unpacking more, with a single tissue sample

Studying disease by taking apart tissue loses something crucial: where everything sits in relation to everything else. Spatial profiling maps cells, genes, and proteins within tissue. A cancer cell beside an immune cell behaves differently from one surrounded by others — helping explain why treatments succeed in some patients but fail in others. SPADE is led by National Cancer Centre Singapore (NCCS), co-led by Singapore General Hospital (SGH) and Duke-NUS Medical School, with a $6 million grant from SingHealth.

“Human tissue is extraordinarily complex, and for a long time we lacked the tools to fully make sense of why diseases behave the way they do, or why the same treatment can work for one patient but not another.”

Assistant Professor Jason Chan

Principal Investigator of SPADE, Director of the Cancer Discovery Hub and Director of Research of the Division of Medical Oncology, National Cancer Centre Singapore (NCCS)

From rare disease to bigger questions

In the future, SPADE's goal is for multiple diagnostic tests to be performed on a single tissue sample, extracting more information without repeatedly putting the patient through biopsies. Researchers could also identify several drug targets from the same sample, opening up possibilities for combination therapies. Towards this goal, NCCS has signed a Research Collaboration Agreement with 10x Genomics, a biotechnology company specialising in single-cell and spatial biology, providing access to advanced spatial profiling technology and supporting new research applications.

SPADE has an even bigger ambition: to build a spatial tissue atlas — a comprehensive molecular map of human tissue. Such an atlas could provide researchers with vast amounts of data to train AI models and develop simulations of how diseases behave.

The longer-term ambition is to move medicine towards something more individualised, away from generalised treatment assumptions. SPADE is SingHealth Duke-NUS AMC's goal to look at diseases not as a single diagnosis, but as a complicated ecosystem of cells — because ultimately, understanding diseases in greater detail helps doctors make better decisions and gives patients a better chance at living well.

This article was first published on 12 November 2026.